1. miR‐216a promotes breast cancer cell apoptosis by targeting PKCα
   Ying Cui et al, 2019, Fundamental & Clinical Pharmacology CrossRef
2. PHLPPing the balance: restoration of protein kinase C in cancer
   Hannah Tovell et al, 2021, Biochemical Journal CrossRef
3. Clinical significance of HRAS and KRAS genes expression in patients with non–small-cell lung cancer - preliminary findings
   Milena Pązik et al, 2021, BMC Cancer CrossRef
4. Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer
   Takahito Kawano et al, 2022, Cancers CrossRef
5. Potential implications of protein kinase Cα in pathophysiological conditions and therapeutic interventions
   Rishi Kant Singh et al, 2023, Life Sciences CrossRef
6. The complexities of PKCα signaling in cancer
   Adrian R. Black et al, 2021, Advances in Biological Regulation CrossRef
7. Progression inference for somatic mutations in cancer
   Leif E. Peterson et al, 2017, Heliyon CrossRef
8. Protein Kinase C Isozymes Associated With Relapse Free Survival in Non-Small Cell Lung Cancer Patients
   Ann Rita Halvorsen et al, 2020, Frontiers in Oncology CrossRef
9. KRAS overexpression independent of RAS mutations confers an adverse prognosis in cytogenetically normal acute myeloid leukemia
   Jing-Dong Zhou et al, 2017, Oncotarget CrossRef
10. MicroRNA-337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways
    Xuerong Liu et al, 2017, Oncology Reports CrossRef
11. Overarching roles of diacylglycerol signaling in cancer development and antitumor immunity
    Mariana Cooke et al, 2022, Science Signaling CrossRef